Human CD34+ cells do not express glutathione S-transferases alpha

Gene Therapy

Volumn 4, Issue 3, 1997, Pages 268-270

  Czerwinski, M ^a,b   Kiem, H P ^b   Slattery, J T ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Busulfan; CD34+ cells; Gene therapy; Glutathione S transferase

Indexed keywords

BUSULFAN; CD34 ANTIGEN; GLUTATHIONE TRANSFERASE; LIVER ENZYME;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DRUG CONJUGATION; GENE THERAPY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

EID: 0030965566     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300381     Document Type: Article

References (17)

1. Kiem H-P et al. Gene therapy and bone marrow transplantation. Curr Opin Oncol 1995; 7: 107-114.
2. Sokolic RA et al. A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression. Blood 1996; 87: 42-50.
3. Flasshove M, Banerjee D, Bertino JR, Moore MA. Increased resistance to methotrexate in human hematopoietic cells after gene transfer of the Ser31 DHFR mutant. Leukemia 1995; 9: S34-S37.
4. Allay JA et al. Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood 1995; 85: 3342-3351.
5. Migita M et al. Selection and enzymatic correction of transduced cells from Gaucher patients using bicistronic vectors containing the genes for glucocerebrosidase and the selectable cell surface antigen, CD24. First Conference on Stem Cell Gene Therapy: Biology and Technology. 1995, (Abstr. 25).
6. Santos GW et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. New Engl J Med 1983; 309: 1347-1353.
7. Mauch P, Down JD, Warhol M, Hellman S. Recipient preparation for bone marrow transplantation. Transplantation 1988; 46: 205-209.
8. 14 C-busulfan in isolated perfused rat liver. Eur J Drug Metab Pkin 1987; 12: 71-76.
9. Marchand DH, Remmel RP, Abdel-Monem MM. Biliary excretion of a glutathione conjugate of busulfan and 1,4-dibromobutane in the rat. Drug Metab Dispos 1988; 16: 85-92.
10. Gibbs JP, Czerwinski M, Slattery JT. Busulfan-glutathione conjugation catalyzed by human liver cytosolic glutathione S-transferase. Cancer Res 1996; 56: 3678-3681.
11. Czerwinski M, Gibbs JP, Slattery JT. Busulfan conjugation by glutathione S-transferases alpha, mu, and pi. Drug Metab Dispos 1996; 24: 1015-1019.
12. Tu C-PD, Qian B. Human liver glutathione S-transferase: complete primary sequence of an Ha subunit cDNA. Biochem Biophys Res Commun 1986; 141: 229-237.
13. Rhoads DM, Zarlengo RP, Tu C-PD. The basic glutathione S-transferases from human liver are products of separate genes. Biochem Biophys Res Commun 1987; 145: 474-487.
14. Kiem H-P et al. Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors. Hum Gene Ther 1995; 7: 89-96.
15. Schecter RL, Cournoyer D, Batist G. Glutathione S-transferase expression in mammary tumours and bone marrow cells Cell Pharmacol 1994; 1: 153-157.
16. Greenbaum M et al. Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers alkylating drug resistance in NIH 3T3 mouse fibroblast. Cancer Res 1994; 54: 4442-4447.
17. Letourneau S, Greenbaum M, Cournoyer D. Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells. Hum Gene Ther 1996; 7: 831-840.